Strategies for Human Tumor Virus Discoveries: From Microscopic Observation to Digital Transcriptome Subtraction

Ezra D Mirvish1, Masahiro Shuda2

  • 1Department of Dermatology, University of Pittsburgh Medical Center, Pittsburgh PA, USA.

Insights

Infectious agents cause over 20% of human cancers. Digital transcriptome subtraction (DTS) is an in silico method that aided in discovering Merkel cell polyomavirus (MCV), a human tumor virus.

Area of Science:

  • Oncology
  • Virology
  • Bioinformatics

Background:

  • Infectious agents, including viruses, are linked to over 20% of global cancer cases.
  • Traditional methods for identifying human tumor viruses are often labor-intensive and may miss novel pathogens.
  • The Human Genome Project has generated vast genetic data, enabling new computational approaches.

Purpose of the Study:

  • To review historical and current methods for discovering human tumor viruses.
  • To explain the development and application of digital transcriptome subtraction (DTS) for identifying novel viruses in human cancers.
  • To highlight the discovery of Merkel cell polyomavirus (MCV) using DTS.

Main Methods:

  • Review of established techniques like electron microscopy, hybridization, and PCR for viral detection.
  • Detailed explanation of the in silico digital transcriptome subtraction (DTS) methodology.
  • Application of DTS to subtract human sequences from transcriptome data to identify non-human sequences.

Main Results:

  • DTS was successfully developed as an in silico method for virus discovery.
  • The DTS method was instrumental in the discovery of Merkel cell polyomavirus (MCV).
  • This approach offers a powerful new avenue for identifying infectious agents associated with cancer.

Conclusions:

  • Digital transcriptome subtraction (DTS) represents a significant advancement in the discovery of human tumor viruses.
  • The identification of MCV underscores the importance of computational methods in virology and oncology.
  • Further application of DTS may lead to the discovery of additional infectious agents implicated in human cancers.